Please login to the form below

Not currently logged in

Merck gets lung cancer OK for Keytruda in US

Merck and Co - US headquarters

Highlights increased understanding of molecular processes in cancer

Genzyme opts into gene silencing therapy for haemophilia

genzyme officesInterim results show positive benefits for ALN-AT3

Clock ticking on biosimilar Enbrel in US

FDA headquarters White Oak10-month review for drug

Novartis signs $500m immuno-oncology deal

Novartis buildingGains access to Xoma's TGFb antibody programme

TEVA buys Mexico’s RIMSA for $2.3bn

Teva Pharma logoFollows acquisition of Allergan’s generic drugs business

A Schengen area of healthcare

Moving to a more coordinated and cooperative European response to health threats

Nutraceuticals and the future of intelligent food

The convergence of food and pharmaceuticals is set to create a huge growth market

MSD launches preventative healthcare accelerator

Joins forces with Wayra Open Future for Velocity Health fund

ABPI's Stephen Whitehead steps down

Leaves the UK pharma trade body after four years as its CEO

Dead man’s shoes

Obsolete business models are making space for the new

darwins medicine

Liberation Unlimited appoints new senior account director

Hayley Jayawardene joins after freelancing-in-house at Pfizer

LIberation Unlimited Hayley Jayawardene

IBM teams up with Teva for eHealth collaboration

Will also partner with ICON on cancer trials project

IBM Watson Health big data

Counting down to the EFPIA Disclosure Code

Communications director Andy Powrie-Smith on why the Code is part of pharma's 'licence to operate'

Taking a strategic approach

Janssen's Cyril Titeux on responding to the industry's pricing, access and reputational challenges

Featured jobs

Subscribe to our email news alerts


Add my company
Complete HealthVizion

Complete HealthVizion is a team outstanding healthcare communications experts who provide innovative strategic evidence based solutions through scientific and commercial...

Latest intelligence

Organisational Memory
In a knowledge-based industry with high labour mobility, retaining that knowledge within an organisation during a drug’s lifecycle can be tricky. If we undervalue the knowledge, experience and marketing understanding...
Thoughts on the intersection between technology and psychology
Paul Mannu - Master Practitioner, Behavioural Insights at Cello Health Insight gives us his succinct thoughts on the intersection between technology and psychology...
Learning to listen - Examining the opportunities and challenges of using conversations on social media for Pharma brands
The world in which we do business has markedly changed since 2008, which has helped to increase the push towards the ‘digitisation’ of marketing communications’ channels, This feature explores the...